SOLENO THERAPEUT. DL-001 (F:6XC) — Stock Price
SOLENO THERAPEUT. DL-001 (F:6XC) is currently trading at €44.86 EUR, up 1.70% today. Over the past 52 weeks, shares have ranged between €25.52 and €59.60. This page tracks SOLENO THERAPEUT. DL-001's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market value of SOLENO THERAPEUT. DL-001.
SOLENO THERAPEUT. DL-001 (6XC) Stock Price Chart — Daily History & Trading Volume
The chart below tracks SOLENO THERAPEUT. DL-001's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.
SOLENO THERAPEUT. DL-001 Income Statement — Revenue, Profit & Earnings by Year
SOLENO THERAPEUT. DL-001's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | €190.41 Million | €0.00 | €0.00 | €0.00 | €0.00 |
| Cost of Revenue | €2.70 Million | €0.00 | €0.00 | — | — |
| Gross Profit | €187.71 Million | €0.00 | €0.00 | — | — |
| Research & Development | €40.63 Million | €78.57 Million | €25.19 Million | €15.27 Million | €21.45 Million |
| SG&A | €132.13 Million | €105.86 Million | €13.48 Million | €9.84 Million | €10.81 Million |
| Total Operating Expenses | €175.46 Million | €184.43 Million | €38.67 Million | €25.11 Million | €32.26 Million |
| Operating Income | €14.95 Million | €-184.43 Million | €-38.67 Million | €-25.11 Million | €-32.26 Million |
| EBITDA | — | — | — | — | — |
| EBIT | — | — | — | — | — |
| Interest Expense | €5.48 Million | €231.00K | €0.00 | €0.00 | — |
| Income Before Tax | €20.89 Million | €-175.85 Million | €-38.99 Million | €-24.07 Million | €-30.91 Million |
| Income Tax Expense | — | — | — | — | — |
| Net Income | €20.89 Million | €-175.85 Million | €-38.99 Million | €-24.07 Million | €-30.91 Million |
SOLENO THERAPEUT. DL-001 Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes SOLENO THERAPEUT. DL-001's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | €563.83 Million | €330.97 Million | €180.69 Million | €26.50 Million | €35.55 Million |
| Total Current Assets | €355.81 Million | €293.89 Million | €171.36 Million | €15.65 Million | €22.42 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | €235.37 Million | €203.51 Million | €0.00 | — | — |
| Net Receivables | €28.21 Million | €0.00 | — | — | — |
| Inventory | €15.02 Million | €0.00 | — | — | — |
| Property, Plant & Equipment | — | — | — | — | — |
| Goodwill | — | — | — | — | — |
| Total Liabilities | €113.72 Million | €85.86 Million | €23.18 Million | €16.15 Million | €17.76 Million |
| Total Current Liabilities | €61.36 Million | €18.75 Million | €11.51 Million | €7.31 Million | €8.01 Million |
| Long-term Debt | €49.86 Million | €49.83 Million | — | — | — |
| Net Debt | — | — | — | — | — |
| Total Stockholder Equity | €450.12 Million | €245.11 Million | €157.51 Million | €10.35 Million | €17.79 Million |
| Retained Earnings | €-431.37 Million | €-452.26 Million | €-276.41 Million | €-237.42 Million | €-213.35 Million |
SOLENO THERAPEUT. DL-001 Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how SOLENO THERAPEUT. DL-001 generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | €46.80 Million | €-69.10 Million | €-24.94 Million | €-20.78 Million | €-27.77 Million |
| Capital Expenditures | €73.00K | €218.00K | €0.00 | €13.00K | €22.00K |
| Free Cash Flow | €46.73 Million | €-69.31 Million | €-24.94 Million | €-20.79 Million | €-27.79 Million |
| Investing Cash Flow | — | — | — | — | — |
| Financing Cash Flow | €137.16 Million | €213.03 Million | €180.02 Million | €14.09 Million | €-128.00K |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | €45.85 Million | €99.96 Million | €5.95 Million | €2.53 Million | €3.28 Million |
| Depreciation | €2.02 Million | €1.99 Million | €1.96 Million | €1.96 Million | €1.96 Million |
| Change in Cash | €-17.82 Million | €-81.75 Million | €155.08 Million | €-6.70 Million | €-27.92 Million |
SOLENO THERAPEUT. DL-001 Earnings History — EPS Actual vs. Analyst Estimates
Track SOLENO THERAPEUT. DL-001's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Aug 05, 2026 | — | 0.71 | — |
| May 11, 2026 | — | 0.50 | — |
| Feb 26, 2026 | — | 0.34 | — |
| Nov 04, 2025 | — | 0.08 | — |
| Jun 06, 2025 | — | — | — |
| Mar 04, 2025 | — | — | — |
| Nov 05, 2024 | — | — | — |
| Jun 30, 2022 | -0.90 | -0.90 | +0.00% |